The WinSanTor team consists of experienced business and regulatory executives and opinion leaders with unique insights into the development of neuropathy treatments and scientific experts with strong track records in the biopharmaceutical industry. WinSanTor also retains a science and technology advisory team composed of renowned experts, industry veterans, and opinion leaders with neuropathy and biopharmaceutical experience. WinSanTor is rigorously pursuing a science-driven approach to translational medicine and clinical development.